Announced Thu, 24 Jul · 19:12 IST

DECLARATION OF RESULT OF REMOTE E-VOTING AND E-VOTING CONDUCTED DURING THE EXTRA-ORDINARY GENERAL MEETING HELD ON TUESDAY 22 JULY,2025 ALONG WITH THE SCRUTINISER REPORT UNDER REGULATION ....

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Kimia Biosciences held an Extra-Ordinary General Meeting on 22 July 2025, where two ordinary resolutions were put to vote via remote e-voting and e-voting at the meeting. Resolution 1 regularized M/s Neeraj Arora & Associates (FRN 021309N) as Statutory Auditors, filling the casual vacancy caused by the resignation of the previous auditors. Resolution 2 regularized Mr. Prasad Raju (Ramakrishnavara Prasada Raju Mantena, DIN 01774224) as Director, who had been appointed as Additional Director effective 24 June 2025. Both resolutions passed with about 99.74% and 99.73% of valid votes in favour respectively. Total voting turnout was 75.28% of outstanding shares (35.6 million out of 47.3 million). Promoter group voted 100% in favour with all 35.46 million shares, while public non-institutions showed notable dissent of around 58-60% against, though public participation was very low at just 1.36% of public shares.

Likely market impact

Routine governance approvals – no material impact expected on share price. Worth noting that public retail shareholders who participated largely voted against both resolutions, signalling some dissatisfaction, though the dissenting share count is small relative to the total capital base.